What is NDC 71335-2353?

71335-2353 is the product NDC for Glipizide, Glipizide 10 mg/1 tablet, extended release, listed with the FDA by Bryant Ranch Prepack. It has 5 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Glipizide?

135 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Glipizide NDC 71335-2353 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2353Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2353Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2353-1	7133523530171335235301	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-1)Marketed from Feb 21, 2024
71335-2353-2	7133523530271335235302	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-2)Marketed from Feb 21, 2024
71335-2353-3	7133523530371335235303	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-3)Marketed from Feb 21, 2024
71335-2353-4	7133523530471335235304	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-4)Marketed from Feb 21, 2024
71335-2353-5	7133523530571335235305	180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-5)Marketed from Feb 21, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glipizide
Generic name (nonproprietary): glipizide
Active ingredients: Glipizide — 10 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206928
Marketing start: Mar 3, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Sulfonylurea Compounds (Chemical structure)
Identifiers: Product ID 71335-2353_bb8758a7-c9c3-4a5f-b96f-3cb8957535c9SPL ID bb8758a7-c9c3-4a5f-b96f-3cb8957535c9SPL set ID 2aa01a7e-a703-426f-9cd3-70b88d0a8e7fRxCUI 315107UNII X7WDT95N5C
Pharmacologic class: Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335235301 followed by a unit qualifier and the quantity

Package 71335-2353-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2026.

Indications (excerpt from the label)

Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-2353

What is NDC 71335-2353?: 71335-2353 is the product NDC for Glipizide, Glipizide 10 mg/1 tablet, extended release, listed with the FDA by Bryant Ranch Prepack. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Glipizide.
What is the active ingredient?: Glipizide.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Glipizide?: 135 other product NDCs are listed under this name. See all Glipizide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Glipizide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Glipizide	Glipizide 5 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-117	11788-0117-0111788-0117-0511788-0117-10
Glipizide	Glipizide 10 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-118	11788-0118-00
Glipizide	Glipizide 2.5 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-120	11788-0120-0111788-0120-0511788-0120-10
Glipizide	Glipizide 5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-579	72789-0579-3072789-0579-6072789-0579-86+3 more
Glipizide	Glipizide 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-580	72789-0580-3072789-0580-6072789-0580-86+3 more
Glipizide	Glipizide 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4178	68788-4178-0168788-4178-0368788-4178-06+2 more
Glipizide	Glipizide 10 mg/1	TabletOral	Coupler LLC	67046-0367	67046-0367-03
Glipizide	Glipizide 5 mg/1	TabletOral	Coupler LLC	67046-0236	67046-0236-03
Glipizide	Glipizide 10 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4061	68788-4061-0168788-4061-0368788-4061-06+2 more
Glipizide	Glipizide 10 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4017	68788-4017-0168788-4017-0368788-4017-06+2 more

All 136 Glipizide NDCs

Other NDCs under ANDA 206928

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206928
Product	Strength	Form · route	Labeler	Product NDC
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	A-S Medication Solutions	50090-6746
Glipizide	Glipizide 10 mg/1	Tablet, Extended releaseOral	A-S Medication Solutions	50090-6765
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	Aurobindo Pharma Limited	59651-781
Glipizide	Glipizide 2.5 mg/1	Tablet, Extended releaseOral	American Health Packaging	60687-768
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	American Health Packaging	60687-881
Glipizide	Glipizide 10 mg/1	Tablet, Extended releaseOral	St. Mary's Medical Park Pharmacy	60760-793
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	St. Mary's Medical Park Pharmacy	60760-794
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3898
Glipizide	Glipizide 10 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4128
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-9742
Glipizide	Glipizide 10 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2614
Glipizide	Glipizide 5 mg/1	Tablet, Extended releaseOral	Northwind Health Company, LLC	82868-025
Glipizide	Glipizide 10 mg/1	Tablet, Extended releaseOral	Northwind Health Company, LLC	82868-035